TB+HIV Updates
PSMID 42nd Annual Convention Lectures
Industry-Sponsored Lecture (Sandoz)
TB+HIV Updates
Speakers:
Daniel Tan, MD, FPCP
Rontgene M. Solante, MD, FPCP, FPSMID
Industry-Sponsored Lecture (Sandoz)
TB+HIV Updates
Speakers:
Daniel Tan, MD, FPCP
Rontgene M. Solante, MD, FPCP, FPSMID
Industry-Sponsored Lecture (Philcare Pharma)
High-Dose (HD) Tigecycline Therapy: A Potent carbapenem-sparing weapon against MDROs (CRE/A. bau)
Speaker: Adrian Joseph L. Buensalido, MD, FPCP, FPSMID
Moderator: Jemelyn U. Garcia, MD, FPC, FPSMID
Industry-Sponsored Lecture (Mylan)
Cardiac, Renal & Pulmonary complications in COVID-19 patients; expert experience in managing/recovery
Speakers:
Rontgene M. Solante, MD, FPCP, FPSMID
Aileen Wang, MD, FPCP, FPCCP
Industry-Sponsored Lecture (GSK)
COVID and AMR: Antibiotic Use During COVID-19 Pandemic and Implication for the Future
Speaker: Adrian Lijavetzki, MD
Industry-Sponsored Lecture (Camber)
Clinical Advances in the management of HIV guidelines and New Evidence
Speaker: Joseph Perriëns, MD, PhD
University of Ghent, Belgium
Industry-Sponsored Lecture (Roche)
Understanding COVID-19: Testing and Optimizing Testing Strategies
Speaker: Aw Tar Choon, MD
Industry-Sponsored Lecture (Pfizer)
Clinicians insights in the Management of Severe CAP, HAP and VAP
Speaker: Albert Rafanan, MD, FPCP, FPCCP
Industry-Sponsored Lecture (Roche)
ONE AND DONE: Reducing the Burden of Adult Influenza through a New Antiviral Treatment with a Novel Mechanism of Action
Speaker: Dominic Dwyer, MD
Industry-Sponsored Lecture (Pfizer)
Ceftaroline in Combating Community-Acquired Pneumonia (CAP)
Speaker: Alex Soriano, MD
Head of Infectious Diseases Department, Hospital Clinic
Assistant Professor, University of Barcelona
Dr. Cynthia Saloma of the Philippine Genome Center explains the difference of SARS-CoV-2 and the new UK Strain Variant. (Source: Department of Health)
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.